Clinical trials
Placebo - Control clinical trials
Below are recruiting placebo - control clinical trials, each written for real people, not researchers. We’re tracking 3,952 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07236788Recruiting
Iron infusion to prevent anemia and improve life in obese patients
This trial tests whether giving an intravenous iron supplement (ferric derisomaltose) can help prevent anemia and improve quality of life in obese patients who have low iron stores. It aims to see if this treatment can boost energy and reduce fatigue.
BeijingAges 18–65 - NCT07236814RecruitingPhase 3
Preventing flu in hospital rooms with two antivirals
This trial tests if taking suraxavir marboxil or oseltamivir can stop the flu from spreading to people sharing a hospital room with a patient who has the flu.
Beijing, Beijing MunicipalityAges 12 years+ - NCT07237464RecruitingPhase 1
Safety study of GB18 injection in healthy adults
This early-phase trial tests a new injection called GB18 in healthy adults to see if it is safe and how the body processes it. It may help researchers understand how to treat conditions that involve the immune system.
Beijing, Beijing MunicipalityAges 18–55 - NCT07237568RecruitingPhase 3
Testing LNK01001 for active ankylosing spondylitis
This trial tests a new oral medication called LNK01001 for adults with active ankylosing spondylitis. It aims to reduce pain, stiffness, and inflammation when standard NSAID treatments no longer help.
BeijingAges 18 years+ - NCT07238400RecruitingPhase 2
Heart medication study for women after preeclampsia
This study tests if a medication called a mineralocorticoid receptor antagonist (MRA) can help improve heart function in women who had preeclampsia and now have high blood pressure and signs of heart thickening.
Boston, MassachusettsAges 18–65 - NCT07238478Recruiting
Supplement for menopause quality of life in postmenopausal women
This trial tests a dietary supplement to see if it can improve menopause-related symptoms, like hot flashes and joint discomfort, in healthy postmenopausal women.
Harrison, New YorkAges 50–70 - NCT07239791Recruiting
Does a low-dose medication affect how we learn?
This study tests whether a very low dose of a medication called atomoxetine, which affects a brain chemical called noradrenaline, can help with how people learn. It is for right-handed adults who are generally healthy and not taking other medications.
ParisAges 18–39 - NCT07239973RecruitingPhase 1
Study of BGM0504 Tablets for overweight or obese adults
This trial tests a new tablet, BGM0504, in healthy adults who are overweight or obese but do not have diabetes. It aims to see how the medicine works and if it is safe for this group.
Kunming, YunnanAges 18–55 - NCT07240558RecruitingPhase 3
Flu vaccine study for organ transplant patients
This study tests whether a special flu vaccine, designed for a future pandemic, works safely in people who have had an organ transplant. It aims to find a better way to protect transplant patients from severe flu.
Toronto, OntarioAges 18 years+ - NCT07240675RecruitingPhase 1
First-in-human safety study of KLA478 in healthy volunteers
This study tests a new drug called KLA478 for the first time in humans. It is looking for healthy volunteers to see how the drug affects the body and how safe it is.
Shanghai, Shanghai MunicipalityAges 18–45 - NCT07240844RecruitingPhase 4
Enavogliflozin for amyloid heart disease
This study tests a drug called enavogliflozin to see if it helps people with a specific type of heart failure caused by amyloid buildup. It may improve symptoms and daily function.
SeoulAges 19 years+ - NCT07241520RecruitingPhase 3
Testing SHPL-49 injection for recent stroke patients
This trial tests a new medication, SHPL-49, given as an injection to people who have just had a stroke caused by a blood clot (ischemic stroke). It is for patients who are already receiving standard clot-busting treatment within 8 hours of symptoms starting. The study will see if adding this drug helps improve recovery.
Linfen, ShanxiAges 18–80 - NCT07241546RecruitingPhase 2
Inhaled study drug for people with mild allergic asthma
This trial tests an inhaled drug called ARO-RAGE to see if it can help people with mild asthma who have allergies. You'll take the drug and then do a special breathing test to see how your lungs respond.
Vancouver, British ColumbiaAges 18–65 - NCT07241585Recruiting
Vitamin D and light therapy for skin cancer
This trial tests whether taking vitamin D before a special light therapy (photodynamic therapy) can help your body fight nonmelanoma skin cancers like basal or squamous cell cancer. You may join if you are scheduled for surgery to remove a skin tumor.
Cleveland, OhioAges 18 years+ - NCT07241910RecruitingPhase 1
Testing the safety of SYH2061 in healthy volunteers
This study tests a single dose of a new medication called SYH2061 to see if it is safe and how the body processes it. It is for healthy adults aged 18 to 55 who have had certain vaccines and are willing to follow study rules.
Hefei, AnhuiAges 18–55 - NCT07241923RecruitingPhase 1
SYH2070 injection safety study for high triglycerides and high cholesterol
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
Shijiazhuang, HebeiAges 18–60 - NCT07244991Recruiting
Effect of a special toothpaste on plaque bacteria and cavities during braces treatment
This trial tests whether a special paste (MI Paste Plus) can reduce cavity-causing bacteria and prevent early white spots on teeth while you are wearing braces.
Tirana, AlbaniaAges 5–45 - NCT07245017RecruitingEarly Phase 1
Testing JN002 drops for dry eye disease
This trial tests whether a new eye drop, JN002, can help people with dry eye disease. It checks if the drops improve symptoms and eye health over time.
ShanghaiAges 18 years+ - NCT07245069RecruitingPhase 2
Can dapagliflozin protect the heart during breast cancer chemo?
This trial tests if the drug dapagliflozin can prevent heart damage caused by anthracycline chemotherapy in breast cancer patients. It aims to see if taking the drug during chemo helps keep your heart healthy.
LjubljanaAges 18 years+ - NCT07245680RecruitingPhase 3
Testing two pills vs one for pulmonary hypertension with heart or metabolism issues
This trial compares starting with two oral medications versus one for people newly diagnosed with pulmonary arterial hypertension (PAH) who also have conditions like high blood pressure, diabetes, obesity, or heart disease. The goal is to see if a two-drug approach works better for patients with these additional health issues.
Le Kremlin-BicêtreAges 18 years+ - NCT07245979Recruiting
Sirtuin activator supplement for overweight women
This study tests whether a supplement that activates sirtuins (proteins that may help with metabolism) can help women who are overweight or have obesity. It looks at changes in body weight and related health markers.
PoznanAges 40–65 - NCT07247734RecruitingPhase 2
Colchicine for insulin sensitivity in type 1 diabetes
This trial tests whether a daily oral medication called colchicine can improve how your body responds to insulin. It is for people with type 1 diabetes who have ongoing low-level inflammation and are already using a continuous glucose monitor.
Gentofte MunicipalityAges 18–80 - NCT07248865RecruitingPhase 1
Study of CLYM116 in healthy volunteers
This study tests a new drug called CLYM116 in healthy adults to see how safe it is and how the body processes it. It may help researchers learn more before testing it in people with certain medical conditions.
BrisbaneAges 18–60 - NCT07250035RecruitingPhase 3
Chinese herb trial for brain bleed linked to amyloid angiopathy
This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.
BeijingAges 50–90
Hear when a new Placebo - Control trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for placebo - control?
- Yes. Clin2 currently lists 3,952 recruiting placebo - control studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a placebo - control trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a placebo - control trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.